[Federal Register Volume 59, Number 176 (Tuesday, September 13, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-22600]
[[Page Unknown]]
[Federal Register: September 13, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on August 15, 1994, Eli Lilly
Industries, Inc., Chemical Plant, Kilometer 146.7, State Road 2,
Mayaguez, Puerto Rico 00680, made application to the Drug Enforcement
Administration (DEA) for registration as a bulk manufacturer of the
Schedule II controlled substance Dextropropoxyphene, bulk (non-dosage
forms) (9273).
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the above application and may also file a written
request for a hearing thereon in accordance with 21 CFR 1301.54 and in
the form prescribed by 21 CFR 1316.47.
Any such comments, objections, or requests for a hearing may be
addressed to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, United States Department of
Justice, Washington, D.C. 20537, Attention: DEA Federal Register
Representative (CCR), and must be filed no later than October 13, 1994.
Dated: September 6, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 94-22600 Filed 9-12-94; 8:45 am]
BILLING CODE 4410-09-M
